npj Regenerative Medicine (Oct 2022)

Myogenic tissue nanotransfection improves muscle torque recovery following volumetric muscle loss

  • Andrew Clark,
  • Subhadip Ghatak,
  • Poornachander Reddy Guda,
  • Mohamed S. El Masry,
  • Yi Xuan,
  • Amy Y. Sato,
  • Teresita Bellido,
  • Chandan K. Sen

DOI
https://doi.org/10.1038/s41536-022-00259-y
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 6

Abstract

Read online

Abstract This work rests on our non-viral tissue nanotransfection (TNT) platform to deliver MyoD (TNTMyoD) to injured tissue in vivo. TNTMyoD was performed on skin and successfully induced expression of myogenic factors. TNTMyoD was then used as a therapy 7 days following volumetric muscle loss (VML) of rat tibialis anterior and rescued muscle function. TNTMyoD is promising as VML intervention.